How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →

Ansun Biopharma Announces First Patient Enrolled In Phase 3 Clinical Trial Evaluating DAS181 In Hospitalized, Immunocompromised Patients With Lower Respiratory Tract Parainfluenza Virus Infection

calendar_today May 28, 2019 person abadmin domain ansun-biopharma